https://www.stocktitan.net/news/IMUX/immunic-inc-reports-third-quarter-2026-financial-results-and-sin4js39z4ti.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-inc-reports-third-quarter-2026-financial-results-and-sin4js39z4ti.html?utm_source=stocktitan-bluesky&utm_medium=social
Hub: https://www.merlintrader.com/immunic-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
Hub: https://www.merlintrader.com/immunic-stock-hub/
Newsletter: https://merlintrader.beehiiv.com/p/week-ahead-10-catalysts-we-re-watching-november-9-13
Immunic, Inc. (Nasdaq: IMUX) furnished under Regulation FD a presentation for its Progressive Multiple Sclerosis (PMS) Research and Development Day webinar held November 5, 2026 from 12:30 to 2:00 p.m.
🧵 continued ↓
Immunic, Inc. (Nasdaq: IMUX) furnished under Regulation FD a presentation for its Progressive Multiple Sclerosis (PMS) Research and Development Day webinar held November 5, 2026 from 12:30 to 2:00 p.m.
🧵 continued ↓
On November 5, 2026, Immunic, Inc. is hosting a Progressive Multiple Sclerosis (PMS) Research and Development Day webinar . The PMS R&D Day will take place on Thursday, November 5, 2026, from 12:30 p.m. to 2:00 p.m. ET via video conference.
On November 5, 2026, Immunic, Inc. is hosting a Progressive Multiple Sclerosis (PMS) Research and Development Day webinar . The PMS R&D Day will take place on Thursday, November 5, 2026, from 12:30 p.m. to 2:00 p.m. ET via video conference.
• Holder: Aberdeen
• Stake: 6.05% → 7.99% (about $8M)
• Shares: 824,393 → 1,090,427
• Filed: Nov 2 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks
• Holder: Aberdeen
• Stake: 6.05% → 7.99% (about $8M)
• Shares: 824,393 → 1,090,427
• Filed: Nov 2 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks
New hub updated: www.merlintrader.com/immunic-stoc...
New hub updated: www.merlintrader.com/immunic-stoc...
New hub updated: www.merlintrader.com/immunic-stoc...
New hub updated: www.merlintrader.com/immunic-stoc...
imux.com/immunic-to-h...
www.merlintrader.com/immunic-stoc...
imux.com/immunic-to-h...
www.merlintrader.com/immunic-stoc...
imux.com/immunic-to-h...
www.merlintrader.com/immunic-stoc...
imux.com/immunic-to-h...
www.merlintrader.com/immunic-stoc...
https://www.stocktitan.net/news/IMUX/immunic-to-host-virtual-progressive-multiple-sclerosis-r-d-day-on-4y4t6fa0stan.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-to-host-virtual-progressive-multiple-sclerosis-r-d-day-on-4y4t6fa0stan.html?utm_source=stocktitan-bluesky&utm_medium=social
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#IMUX
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#IMUX
https://www.merlintrader.com/immunic-stock-hub/
https://www.merlintrader.com/immunic-stock-hub/
https://www.stocktitan.net/news/IMUX/immunic-presents-new-clinical-biomarker-and-preclinical-data-for-mx1w9ep9v2nn.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-presents-new-clinical-biomarker-and-preclinical-data-for-mx1w9ep9v2nn.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.merlintrader.com/immunic-stock-hub/
https://www.merlintrader.com/immunic-stock-hub/
https://www.stocktitan.net/news/IMUX/immunic-appoints-jaa-roberson-as-chief-people-m1tbutw77o1f.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-appoints-jaa-roberson-as-chief-people-m1tbutw77o1f.html?utm_source=stocktitan-bluesky&utm_medium=social
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/immunic-stoc...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/immunic-stoc...
https://www.stocktitan.net/news/IMUX/immunic-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-r5ze19shxahv.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-r5ze19shxahv.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-j05qhna3jp2d.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IMUX/immunic-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-j05qhna3jp2d.html?utm_source=stocktitan-bluesky&utm_medium=social
Nagel Robert Thorvald () reported special transactions (Non-P/S).
Nagel Robert Thorvald () reported special transactions (Non-P/S).
Analysis Error
Analysis Error
Exhibit Number Description 104 Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.
Exhibit Number Description 104 Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.